Clinical Trial Details
EORTC-30951
Back to Clinical Trials Database
Randomized phase II trial of Interferon alpha-2a with and without 13-cis Retinoic Acid in patients with progressive metastatic renal cell carcinoma Amendment protocol: Extension to a randomized phase III trial
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 05-Mar-1996 Date Step1 close: 24-Jan-2001 |
Data management at EORTC | Yes |
Design |
Phase 3 Randomized open label |
Targeted Sample size | EORTC Groups: 296 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/NCT00002737 |
NCT number | NCT00002737 |